IL37 and spondyloarthropathy: From the step forward, we can understand the pathophysiology behind Psout, especially with the ability of MSU crystals to interfere with the interleukin 23/17 (IL-23/IL-17) axis, the main pathological pathway in seronegative spondyloarthropathies [39].